Financial Results for June 30, 2014 (Standalone)
Venus Remedies Ltd has informed BSE about the Standalone Financial Results for the period ended June 30, 2014.13-08-2014
13-08-2014
Revised Shareholding Pattern for June 30, 2014
With reference to earlier announcement dated July 10, 2014 regarding Shareholding Pattern for June 30, 2014, Venus Remedies Ltd has now submitted to BSE the Revised Shareholding Pattern for June 30, 2014.01-08-2014
Shareholding Pattern For June 30, 2014
Venus Remedies Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014.12-07-2014
Updates on Financial Results for March 31, 2014
Venus Remedies Ltd has submitted to BSE a copy of Corrected copy of the Financial Results for the period ended March 31, 2014.11-07-2014
VMRC Drug VRP008 to Fight "MULTI-DRUG Resistant Bacteria" Receives European Patent
Venus Remedies Ltd has informed BSE regarding "VMRC Drug VRP008 to Fight "MULTI-DRUG Resistant Bacteria" Receives European Patent".03-06-2014
Board recommends Dividend
Venus Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2014, inter alia, has recommended a dividend @ of 30% i.e. Rs. 3/- per share for the financial year ended March 31, 2014 subject to approval of the same by shareholders at the Annual General Meeting.30-05-2014
Financial Results for March 31, 2014 (Audited)
Venus Remedies Ltd has informed BSE about the Financial Results for the period ended March 31, 2014.30-05-2014
Venus Remedies bags additional patent for Vancoplus from US
Venus Remedies Ltd has informed BSE regarding "Venus Remedies bags additional patent for Vancoplus from US"26-05-2014
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Venus Remedies Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199221-05-2014